Drug Stocks Drop on Trump’s Price Bidding Comments

The video discusses the impact of Donald Trump's press conference on the pharmaceutical market, highlighting his unexpected stance against high drug prices. It compares US drug pricing strategies with those in other countries and examines market reactions. The video also explores potential lobbying efforts by the pharmaceutical industry to counteract Trump's proposals.

What are the potential consequences for pharmaceutical companies if the government negotiates drug prices?

How are drug lobbyists expected to respond to Trump's proposals on drug pricing?